GH vs LEN · rev $739.0M vs rev $34.19B
Guardant Health Inc (GH) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Guardant Health Inc (GH) is a diagnostics & research company listed on US.
LEN (LEN) common stock.
Latest reported GH revenue for 2024-12-31 was $739.0M. Net income was -$436.4M. Revenue was up 31.0% from 2023-12-31 to 2024-12-31. GH currently screens at market cap $6.32B.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
GH currently screens at market cap $6.32B. LEN currently screens at market cap $0.
Not investment advice. Open the GH and LEN stock pages for the full models.
Not investment advice.